Delivery Order SPE2DB24D1205-SPE2DB25FCZLA
Award Date 8/12/25
Potential Completion Date 9/3/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a contract ceiling value of $1,804.13. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) under a firm fixed-price contract valued at $4,712.76, with completion targeted for September 10, 2025. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical supplier within the...
- The Defense Logistics Agency awarded a $13.7K delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 4 mg tablets (100-count) under a firm fixed-price contract valued at $5,412.39, with an ultimate completion date of November 26, 2025. This non-set-aside award was competitively procured and represents a single delivery order within AmerisourceBergen's larger contract portfolio with DLA. The place of performance is listed as the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,263.75 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Envarsus XR 1 mg tablets in quantities of 100 units. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by November 12, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,000.80 on November 5, 2025, for the supply of Envarsus XR 4 mg tablets (100 count). The contract is a firm fixed-price delivery order with an ultimate completion date of November 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Envarsus XR 4 mg tablets (100-count) under a firm fixed-price contract valued at $1,711.95. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This competitive award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete successfully in federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,151.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects AmerisourceBergen's capability to compete...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Envarsus XR 0.75 mg tablets (30-count) with a ceiling value of $2,339.52. This delivery order represents a competitive, firm fixed-price procurement with no set-aside designation and is scheduled for ultimate completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 4 mg tablets (100-count) valued at $10,271.70 under firm fixed price terms. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 7, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical...